Q/C Technologies EBIT

As of the most recent data (March 2026), QCLS shows a EBIT of $-9.2M. That compares with $-14M in the prior-year period — up 35.7% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, QCLS's EBIT is now $-9.2M (was $-14M) — a 35.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Q/C Technologies is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Q/C Technologies is at $-9.2M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how QCLS stacks up against individual peers as well.

Tracking QCLS's ebit over time shows whether Q/C Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $-9.2M That compares with $-14M in the prior-year period — up 35.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Q/C Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-9.2M) with ownership activity and broader fundamentals.